esorubicin has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blough, RR; Johnson, CM; Kilton, LJ; Lad, TE; Rose, C; Rosen, ST; Rossof, AH; Schor, J | 1 |
Green, M; Modeas, C; Muss, HB; Norton, L; Perry, MC; Propert, KJ; Ringenberg, QS; Schilsky, RL; Weiss, RB | 1 |
Graziano, S; Green, M; Hirsh, V; Modeas, C; Perry, MC; Propert, KJ; Richards, F; Ringenberg, QS; Weiss, RB | 1 |
Abrams, J; Aisner, J; Conley, BA; Eisenberger, M; Hiponia, D; Hornedo, J; Van Echo, DA | 1 |
1 trial(s) available for esorubicin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Multicenter Studies as Topic | 1990 |
3 other study(ies) available for esorubicin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Pancoast Syndrome | 1990 |
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.
Topics: Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Humans; Lung Neoplasms | 1988 |
Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |